CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria
Clinical trial NCT03477422 · COMPLETED
Trial details
- NCT number
- NCT03477422
- Sponsor
- Venus Remedies Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-11
- Primary completion
- 2017-05-08
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.